Vanda Pharmaceuticals Inc. (VNDA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
VNDA currently has 59M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 1.52% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jul 31, 2025 |
10-Q filing | 59.0M shares outstanding |
59M | 0 |
| May 08, 2025 |
10-Q filing | 58.5M shares outstanding |
59M | 0 |
| Feb 14, 2025 |
10-K filing | 58.1M shares outstanding |
58M | 0 |
| Nov 07, 2024 |
10-Q filing | 58.3M shares outstanding |
58M | 0 |
| Aug 01, 2024 |
10-Q filing | 58.2M shares outstanding |
58M | 0 |
| May 09, 2024 |
10-Q filing | 57.8M shares outstanding |
58M | 0 |
| Feb 08, 2024 |
10-K filing | 57.6M shares outstanding |
58M | 0 |
| Nov 09, 2023 |
10-Q filing | 57.5M shares outstanding |
58M | 0 |
| Jul 28, 2023 |
10-Q filing | 57.5M shares outstanding |
58M | 0 |
| May 03, 2023 |
10-Q filing | 57.4M shares outstanding |
57M | 0 |
| May 03, 2023 |
S-3/A filing: This is an S-3/A filing that includes exhibits such as the form of underwriting agreement, amended and restated certificate of incorporation, fourth amended and restated bylaws, specimen certificate representing the common stock, form of indenture, form of debt security, form of warrant agreement, form of certificate of designation, form of unit agreement, opinion of Orrick, Herrington & Sutcliffe LLP, consent of Orrick, Herrington& Sutcliffe LLP, consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm, and power of attorney. |
57M | 0 |
| Feb 09, 2023 |
S-3 filing: Vanda Pharmaceuticals Inc. files an S-3 form for a mixed shelf offering of preferred stock, common stock, and debt securities, with a total proposed amount of $200,000,000. |
57M | 0 |
| Feb 09, 2023 |
10-K filing | 57.0M shares outstanding |
57M | 0 |
| Nov 03, 2022 |
10-Q filing | 56.6M shares outstanding |
57M | 0 |
| Aug 04, 2022 |
10-Q filing | 56.5M shares outstanding |
57M | 0 |
| May 06, 2022 |
10-Q filing | 56.1M shares outstanding |
56M | 0 |
| Feb 24, 2022 |
10-K filing | 55.5M shares outstanding |
56M | 0 |
| Nov 04, 2021 |
10-Q filing | 55.7M shares outstanding |
56M | 0 |
| Jul 29, 2021 |
10-Q filing | 55.6M shares outstanding |
56M | 0 |
| May 06, 2021 |
10-Q filing | 55.1M shares outstanding |
55M | 0 |
| Feb 11, 2021 |
10-K filing | 55.2M shares outstanding |
55M | 0 |
| Oct 29, 2020 |
10-Q filing | 54.7M shares outstanding |
55M | 0 |
| Aug 06, 2020 |
10-Q filing | 54.5M shares outstanding |
55M | 0 |
| May 07, 2020 |
10-Q filing | 53.8M shares outstanding |
54M | 0 |
| Feb 26, 2020 |
10-K filing | 53.1M shares outstanding |
53M | 0 |